DGX vs IRMD · P/E 22, rev $5.94B vs P/E 51, rev $42.4M
Quest Diagnostics Incorporated (DGX) versus Iradimed Co (IRMD) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Iradimed Co (IRMD) is a medical devices company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Not investment advice. Open the DGX and IRMD stock pages for the full models.
Not investment advice.